Meeder Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Meeder Advisory Services's AZN Position: Q2 2026 in Review
Meeder Advisory Services increased its AstraZeneca (AZN) stake by 40% in Q2 2026, buying an estimated $86.9K and bringing the position to 1,612 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #552.
Meeder Advisory Services first reported a position in AZN in Q2 2024 and has held it in 4 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Meeder Advisory Services held 1,612 shares of AstraZeneca worth $306K as of Q2 2026.
- Meeder Advisory Services bought 462 AstraZeneca shares in Q2 2026, an estimated $86.9K.
- AstraZeneca made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #552 holding.
- Meeder Advisory Services first reported a position in AstraZeneca in Q2 2024 and has held it in 4 quarters since.
- 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.